Floatz logo

Incb099280

Advanced Solid Tumor

Incyte CorporationPhase 2Active
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
59/ 100

Competitive context

1411 Active assets in the Advanced Solid Tumor cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
Inno-206
M.D. Anderson Cancer Center
Phase 2BB
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
PROPOFOL
Hong Kong Children's Hospital
Phase 4BB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

Incb099280 is also rated in:

cutaneous neuroendocrine carcinomaDormant
C
Indicative ·
34 / 100
View asset →
MSI-H/dMMR TumorsDormant
C
Indicative ·
34 / 100
View asset →
skin squamous cell carcinomaDormant
C
Indicative ·
34 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →